Vimarsana
Biggest News Aggregation in the World

Page 31 - Lexaria Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lexaria Bioscience Today - Breaking & Trending Today

Lexaria Bioscience Corp.: Lexaria Provides Annual Letter From the CEO - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Provides Annual Letter From the CEO

KELOWNA, BC / ACCESSWIRE / January 27, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to provide an

Lexaria Bioscience Corp.: Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2 - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2

"Cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2"KELOWNA, BC / ACCESSWIRE / January 18, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or

Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2 - Vimarsana News

Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2

18.01.2022 - 'Cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2'KELOWNA, BC / ACCESSWIRE / January 18, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery ... Seite 1

Hill Street Beverage Company Inc.: Hill Street Jumpstarts New Year Announcing Appointment of Permanent CEO and Continued Growth Momentum - Vimarsana News

Hill Street Beverage Company Inc.: Hill Street Jumpstarts New Year Announcing Appointment of Permanent CEO and Continued Growth Momentum

Toronto, Ontario--(Newsfile Corp. - January 6, 2022) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or the "Company") announces the appointment of a permanent CEO and new progress made

Lexaria Bioscience Corp.: Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4 - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4

• Dosing is expected to begin by April, 2022KELOWNA, BC / ACCESSWIRE / December 29, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug